Skip to main content
Figure 1 | Harm Reduction Journal

Figure 1

From: The feasibility of an intensive case management program for injection drug users on antiretroviral therapy in St. Petersburg, Russia

Figure 1

CD4 at Baseline and last follow-up visit. Figure 1 provides data on baseline (ART initiation) and last follow-up CD4 result by levels of retention. At initiation the total median CD4 was 215 cells/mL with the median among the group who stopped ART at 160 cells/mL. There was no difference in the median CD4 count between the three groups at baseline (p = 0.33). There was a statistically significant improvement in the CD4 count at the last follow-up visit compared to the baseline visit for the groups that were completely or partially adherent, but not for the group that stopped ART prior to the 8 month visit.

Back to article page

Harm Reduction Journal

ISSN: 1477-7517